Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Progestin
100%
Retrospective Cohort Study
100%
Contraceptives
100%
Medical Abortion
100%
Mifepristone
55%
Medroxyprogesterone Acetate
55%
Etonogestrel Implant
44%
Confidence Interval
33%
Implant Placement
22%
Contraceptive Counseling
22%
St. Paul
11%
Randomized Controlled Trial
11%
Health Centers
11%
Electronic Health Records
11%
Subdermal
11%
Clinical Information
11%
Clinical Treatment
11%
Odds Ratio
11%
Logistic Regression
11%
Uterus
11%
Inclusion Criteria
11%
Treatment Failure
11%
Additional Treatment
11%
Failure Rate
11%
Information Deficit
11%
Loss-to-follow-up
11%
Concurrent Administration
11%
Planned Parenthood
11%
Ongoing Pregnancy
11%
Gestational Duration
11%
Patient Model
11%
Postpartum Contraception
11%
Abortion Patients
11%
Etonogestrel Contraceptive Implant
11%
Medicine and Dentistry
Retrospective Cohort Study
100%
Gestagen
100%
Contraceptive Agent
100%
Medical Abortion
100%
Medroxyprogesterone Acetate
55%
Mifepristone
55%
Etonogestrel
55%
Depo-Provera
55%
Implant
33%
Implant Placement
22%
Counseling
22%
Electronic Health Record
11%
Randomized Controlled Trial
11%
Logistic Regression Analysis
11%
Planned Parenthood
11%
Contraceptive Implant
11%
Odds Ratio
11%
Primary Outcome
11%
Abortion Patient
11%
Neuroscience
Progestin
100%
Depo-Provera
100%
Nexplanon
100%
Mifepristone
100%
Randomized Controlled Trial
20%